Exploring emerging clinical trial hubs in EECCA: webinar
Event recap and key takeaways | March 18, 2025
Our expert panel provided a comprehensive examination of the regulatory environment, operational challenges, and strategic opportunities in the EECCA region. Here are some of the critical insights shared during the two-hour session:
The EECCA region continues to make significant progress in harmonizing regulatory frameworks, though each country presents unique challenges and timelines. Understanding local requirements while navigating broader regional trends remains essential for successful trial implementation.
The clinical trial infrastructure across Eastern Europe, Caucasus and Central Asia is expanding, with increasing numbers of qualified sites, experienced investigators, and improved patient recruitment capabilities. However, sponsors must carefully evaluate site capabilities and invest in strong relationships with local partners.
Success in the EECCA region requires:
Deep understanding of country-specific regulations
Cultural sensitivity and local expertise
Strong site selection and management processes
Flexible operational strategies that account for regional variations
Investment in long-term partnerships with experienced local teams
Our distinguished panel brought decades of combined experience working in the region:
Panel Members:
Vadym Kutsenok - Director, Country Site Activation Head for Ukraine & Hungary, IQVIA
Tamar Bolkvadze - Country MD, Georgia, OXIMIO
Alex Shakhov - Sr. Manager Clinical Trial Liaison, Global Site Management, REGENERON
Olga Vizgalova - Regional Director CEE, OXIMIO
Pavlo Garkaviy - Senior International Medical Director, NOVO NORDISK
Dr. Manthinda Hettiarachchi - Senior Project Director & Global Therapeutic Area Head, GEORGE CLINICAL
Expertly moderated by: Diana Matiashvili - Founder & CEO, PASPIGIONI
Each panelist shared practical experiences, real-world challenges, and proven strategies for navigating the complexities of conducting clinical trials in emerging markets. The interactive format allowed participants to gain insights directly applicable to their own clinical trial programs.
The EECCA region represents a significant opportunity for clinical research expansion. As these markets continue to mature, sponsors who invest in understanding the landscape, building strong partnerships, and approaching the region strategically will be well-positioned for success.
Interested in learning more about conducting clinical trials in the EECCA region? Contact PASPIGIONI to discuss how we can support your clinical research initiatives.